Cysteine peptidase and its inhibitor activity levels and vitamin E concentration in normal human serum and colorectal carcinomas

World Journal of Gastroenterology

Volumn 11, Issue 6, 2005, Pages 850-853

  Szwed, Robert ^a   Grzebieniak, Zygmunt ^a   Saleh, Yousif ^a   Ekonjo, Godwin Bwire ^a   Siewinski, Maciej ^a  

^a WROCLAW MEDICAL UNIVERSITY   (Poland)

Author keywords

Colorectal cancers; Cysteine peptidases; Inhibitors; Vitamin E

Indexed keywords

ALPHA TOCOPHEROL; CYSTEINE PEPTIDASE INHIBITOR; ENZYME INHIBITOR; PEPTIDASE; PROTEINASE; UNCLASSIFIED DRUG;

ADULT; AGED; ARTICLE; CANCER INVASION; COLORECTAL CARCINOMA; CONTROLLED STUDY; CORRELATION ANALYSIS; DISEASE COURSE; ENZYME ACTIVITY; ENZYME BLOOD LEVEL; FEMALE; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; IMMUNE SYSTEM; MALE; PROTEIN BLOOD LEVEL; PROTEIN EXPRESSION; VITAMIN BLOOD LEVEL;

EID: 14544271878     PISSN: 10079327     EISSN: None     Source Type: Journal    
DOI: 10.3748/wjg.v11.i6.850     Document Type: Article

References (28)

1. Strauli P. A concept of tumor invasion. Strauli P, Barrett AJ, Baici A. eds. Proteinase and tumor invasion. wdy. Raven Press, New York, pp. 1980: 157-170
2. 3odowskie Curie, Warsaw, Poland, 1993
3. 3odowskie Curie, Warsaw, Poland, 1993
4. Hohensee E. Map of the cancer atlas "Atlas of cancer mortality in Central Europe. IIARC scientific publications No134, Lyon, 1995
5. Fearon E, Vogelstein B. Genetic model for colorectal tumorigenesis. Cell 1990; 61: 759-767
6. Harbeck N, Alt U, Berger U, kruger A, Thomssen C, Janicke F, Hofler H, Kates RE, Schmitt M. Prognostic impact of proteolytic factors (urokinase-type plasminogen activator, plasminogen activator inhibitor 1, and cathepsins B, D, and L) in primary breast cancer reflects effects of adjuvant systemic therapy. Clin Cancer Res 2001; 7: 2757-2764
7. Siewinski M, Gutowicz J, Zarzycki A, Mikulewicz W. Activity of cysteine protease inhibitors in human brain tumors. Med Sci Monit 2001; 7: 675-679
8. Schotte P, Van Criekinge W, Van de Craen M, Van Loo G, Desmedt M, Grooten J, Cornelissen M, De Ridder L, Vandekerckhove J, Fieders W, Vandenabeele P, Beyaert R. Cathepsin B-mediated activation of proinflammatory caspase-11. Biochem Biophys Res Commun 1998; 251 379-387
9. Adenis A, Huet G, Zerimech F, Hecquet B, Balduyck M, Peyrat JP. Cathepsin B, L, and D activities in colorectal carcinomas: Relationship with clinico-pathological parameters. Cancer Lett 1995; 96: 267-275
10. Herszenyi L, Farinati F, Plebani M, Carraro P, Roveroni G, De Paoli Cardin M, Naccarato R, Tulassay Z. Prognostic role of cysteine and serin proteases in gastric cancer. Orv Hetil 1996; 137: 1637-1641
11. Siewinski M. Autologous cysteine peptidase inhibitors as potential anticancer drugs. Anti Cancer Drugs 1993; 4: 97-98
12. Hugli TE. Protease inhibitortors: Novel therapeutic application and development. Trends Biotechnol 1996; 14: 409-412
13. Longnecker MP, Martin-Moreno JM, Knekt P, Nomura AM, Schober SE, Stahelin HB, Wald NJ, Gey KF, Willett WC. Serum alpha-tocopherol concentration in relation to subsequent colorectal cancer: pooled data from five cohorts. J Nat Cancer Inst 1992; 84: 430-435
14. Prasad KN, Cohrs RJ, Sharma OK. Decreased expression of c-myc and H-ras oncogenes in vitamin E succinate induced morphologically differentiated murine B-16 melanoma cells in culture. Biochem Cell Biol 1990; 68: 1250-1255
15. Sakamoto W, Yoshikawa K, Shinadoh M, Ameyama A, Handa O, Saeki T, Nagasava S, Koyama J, Ogihara T, Mino M. In vivo effect of vitamin E on peritoneal macrophages and T-kininogen level rats. Int J Vitam Nutr Res 1989; 59: 131-139
16. Cascinu S, Ligi M, Del Ferro E, Foglietti G, Cioccolini P, Staccioli MP, Carnevali A, Luigi Rocchi MB, Alessandroni P, Giordani P, Catalano V, Polizzi V, Agostinelli R, Muretto P, Catalano G. Effects of calcium and vitamin supplementation on colon cell proliferation in colorectal cancer. Cancer Invest 2000; 18: 411-416
17. Krecicki T, Siewiñski M. Serum cathepsin B-like activity as potential marker of laryngeal carcinoma. European Arch Otorhinolaryngol 1992; 249: 293-295
18. Siewinski M, Gutowicz J, Kielan W, Bolanowski M. Cysteine peptidase inhibitors and activator (s) in urine of patients with colorectal cancer. Oncology 1994; 51: 446-449
19. Nilsson B, Johansson B, Johansson L, Holmberg L. Determination of plasma a-tocopherol by high-performance liquid chromatography. J Chromatography 1978; 145: 169-172
20. Kos J, Werle B, Lah T, Brunner N. Cysteine proteinase and their inhibitors in extracellular fluids. Marker for diagnosis and prognosis in cancer. Int J Biol Markers 2000; 15: 84-89
21. Storer AC, Menard R. Catalytic mechanism in the papain family of cysteine peptidases. Methods Enzymol 1994; 244: 486-500
22. Kos J, Lah TT. Cysteine proteinases and their endogenous inhibitors: Target proteins for rognosis, diagnosis and therapy in cancer (Review). Oncol Rep 1998; 5: 1349-1361
23. Lah T, Kos J. Cysteine proteinases in cancer progression and their clinical relevance for prognosis. Biol Chem 1998; 379: 125-130
24. Troy AM, Sheahan K, Mulcahy HE, Duffy MJ, Hyland JMP, O'Donoghue DP. Expression of cathewpsin B and L antigen and activity is associated with early colorectal cancer progression. Eur J Cancer 2004; 40: 1610-1616
25. Iacobuzio-Donahue C, Shuja S, Cai J, Peng P, Willet J, Murnane M. Cathepsin D protein levels in colorectal tumors: Diverent expression patterns suggest complex regulation and function. Int J Oncol 2004; 24: 473-485
26. Leonetli C, Biroccio A, Gabellini C, Scarsella M, Maresca V, Flori E, Bove L, Pace A, Stoppacciaro A, Zupi A, Cognetti F, Picardo M. alpha-tocopherol protects against cisplatin-induced toxicity without interfering with antitumor efficiency. Int J Cancer 2003; 104: 243-250
27. Yam D, Peled A, Shinitzky M. Suppression of tumor growth and metastasis by dietary fish oil combined with vitamins E and C and cisplatin. Cancer Chemother Pharmacol 2001; 47: 34-40
28. Saleh Y, Siewinski M, Sebzda T, Grybos M, Pawelec M, Janocha A. Effect of combined In vivo treatment of transplantable solid mammary carcinoma in Wistar rats using vitamin E and cysteine peptidase inhibitors from human placenta. J Exp Therap Oncol 2003; 3: 1-8